Featured Article
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Latest Features
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Managing Heart Failure: Improving Quality of Life and Preventing Excerbations
Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.
Preventing Heart Failure One Risk Factor at a Time
Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.
Hope for Heart Failure in Thyroid Hormone Therapy
Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.
Premature Ventricle Contractions in Heart Failure: A Closer Examination
A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.
ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD
While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.
Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"
Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.
Managing Cardiovascular Complications of Oncology Treatment
Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.
Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure
Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.
Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD
Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.
Latest News
Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes
Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease.
Sacubitril-Valsartan Superior to Enalapril for Reducing NT-proBNP in HFrEF
A sacubitril-valsartan therapy regimen was associated with greater reductions in NT-proBNP concentrations in patients with HFrEF compared with enalapril.
Use of Both Aspirin and NSAIDs Associated With Incident Heart Failure Risk
The use of both NSAID and aspirin was positively associated with incident HF in adults with no prior history of CVD.
IABP Devices Being Evaluated By the FDA Due to Battery Complications
There have been over 75 medical device reports of the cardiac assist Maquet/Datascope IABP devices shutting down while running on battery.
Data Support Efficacy of Heart Failure Hospital Readmissions Reduction Program
The US Hospital Readmissions Reduction Program (HRRP) has successfully reduced readmission rates for certain conditions.
Risk for Congestive Heart Failure During Pregnancy in Cancer Survivors
Investigators sought to determine the incidence of cardiac decompensation during pregnancy in cancer survivors.
Some Antirheumatic Medications May Be Associated With Increased Heart Failure Risk in RA
A diagnosis of cardiovascular disease or presence of related biomarkers, as well as the use of antirheumatic drugs may be associated with a higher risk for heart failure in patients with rheumatoid arthritis.
3D Echocardiography May Affect Decision to Implant an ICD in Subset of Patients
LVEF values measured with 3DE were stronger predictors of major arrhythmic events than the same values calculated with 2DE.
Treatment for Transthyretin Amyloidosis Granted Orphan Drug Designation
The Company expects to start Phase 3 studies for ATTR cardiomyopathy and polyneuropathy in the first half of 2019.
Periprocedural ICD Complication Rates Among Older Adults Hospitalized With Heart Failure
Patients currently or recently hospitalized for heart failure undergoing initial ICD placement experienced a higher rate of composite periprocedural complications compared with those without a recent heart failure hospitalization.
The Cardiology Advisor Articles
- AHA/ACC Release Updated Guidelines for Cholesterol Management
- Bacterial Pneumonia Associated With Increased Risk for Future MACE
- Updated Physical Activity Guidelines Released at AHA Scientific Sessions 2018
- Omega-3 Fatty Acids Reduce MACE in Mild Hypertriglyceridemia
- Diuretic Regimen More Effectively Reduces CV Morbidity vs Telmisartan Combinations in Hypertension With Diabetes
- AHA/ACC Release Updated Guidelines for Cholesterol Management
- DOAC Safety, Efficacy Similar to Warfarin for Nonvalvular Atrial Fibrillation
- Statin-Induced Myalgia Unrelated to Muscle Coenzyme Q10 Level
- Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk
- Icosapent Ethyl Reduces Ischemic Event Risk in Patients With Hypertriglyceridemia Despite Statin Use
- Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia
- CVD May Be Associated With Neuronal Loss in Treated HIV+ Patients
- Total CV Event Reduction More Effectively Assesses Alirocumab Efficacy After ACS
- Red Cross Issues Urgent Call for Blood Ahead of the Holidays
- Updated Guidelines Stress Healthy Lifestyle for Cholesterol Management